Benzinga | Nov 9, 2021 11:28AM EST

Immuneering Q3 EPS $(0.47) Up From $(0.89) YoY

Immuneering (NASDAQ:IMRX) reported quarterly losses of $(0.47) per share. This is a 47.19 percent increase over losses of $(0.89) per share from the same period last year.